E. Widerl�v

845 total citations
13 papers, 698 citations indexed

About

E. Widerl�v is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, E. Widerl�v has authored 13 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 3 papers in Psychiatry and Mental health. Recurrent topics in E. Widerl�v's work include Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). E. Widerl�v is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neuropeptides and Animal Physiology (4 papers). E. Widerl�v collaborates with scholars based in Sweden. E. Widerl�v's co-authors include Markus Heilig, Tommy Lewander, E. �ngg�rd, Michael Nilsson, Claes Wahlestedt, Leif H. Lindstr�m, Göran Stening, Rolf Ekman, Jan Andersson and Christer Alling and has published in prestigious journals such as Psychopharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology and Journal of Neural Transmission.

In The Last Decade

E. Widerl�v

13 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Widerl�v Sweden	11	422	272	147	120	108	13	698
A Dlabac Czechia	7	414 1.0×	289 1.1×	89 0.6×	141 1.2×	92 0.9×	71	940
Roberto DeLucia Brazil	12	236 0.6×	169 0.6×	123 0.8×	41 0.3×	111 1.0×	41	493
Carol J. Grossman United Kingdom	7	585 1.4×	475 1.7×	133 0.9×	54 0.5×	92 0.9×	8	1.0k
Patricia Arnaiz Switzerland	10	445 1.1×	226 0.8×	190 1.3×	120 1.0×	113 1.0×	24	617
Bjarne Fjalland Denmark	18	520 1.2×	376 1.4×	91 0.6×	45 0.4×	116 1.1×	45	1.0k
Henriette Francès France	19	448 1.1×	422 1.6×	126 0.9×	52 0.4×	147 1.4×	32	1.1k
Fuller Rw United States	12	257 0.6×	112 0.4×	116 0.8×	41 0.3×	86 0.8×	49	556
L. Eroğlu Türkiye	13	235 0.6×	166 0.6×	110 0.7×	28 0.2×	87 0.8×	40	600
David J. Barber United Kingdom	17	446 1.1×	245 0.9×	68 0.5×	148 1.2×	88 0.8×	33	773
John P. Braselton United States	11	290 0.7×	148 0.5×	353 2.4×	173 1.4×	162 1.5×	17	766

Countries citing papers authored by E. Widerl�v

Since Specialization

Citations

This map shows the geographic impact of E. Widerl�v's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Widerl�v with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Widerl�v more than expected).

Fields of papers citing papers by E. Widerl�v

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Widerl�v. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Widerl�v. The network helps show where E. Widerl�v may publish in the future.

Co-authorship network of co-authors of E. Widerl�v

This figure shows the co-authorship network connecting the top 25 collaborators of E. Widerl�v. A scholar is included among the top collaborators of E. Widerl�v based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Widerl�v. E. Widerl�v is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Heilig, Markus, et al.. (1990). Effects of centrally administered neuropeptide Y (NPY) and NPY13?36 on the brain monoaminergic systems of the rat. Journal of Neural Transmission. 79(3). 193–208. 66 indexed citations

Heilig, Markus, et al.. (1989). Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology. 98(4). 524–529. 326 indexed citations

Widerl�v, E., et al.. (1989). Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man. European Journal of Clinical Pharmacology. 37(4). 359–363. 10 indexed citations

Ekman, Rolf, et al.. (1989). Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat. Journal of Neural Transmission. 78(3). 209–220. 16 indexed citations

Andersson, Jan, et al.. (1988). Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia. Psychopharmacology. 94(2). 167–71. 17 indexed citations

Emanuelsson, B.‐M., et al.. (1987). Determinations of 5-hydroxyindoleacetic acid and homovanillic acid in human CSF with monitoring of probenecid levels in CSF and plasma. Psychopharmacology. 92(2). 144–9. 6 indexed citations

Lindstr�m, Leif H., et al.. (1985). An open study of remoxipride, a benzamide derivative, in schizophrenia. Psychopharmacology. 86(1-2). 241–243. 33 indexed citations

Widerl�v, E., et al.. (1983). Pharmacokinetics of methadone in methadone maintenance treatment: Characterization of therapeutic failures. European Journal of Clinical Pharmacology. 25(4). 497–501. 33 indexed citations

Nilsson, Michael, et al.. (1982). Effect of urinary pH on the disposition of methadone in man. European Journal of Clinical Pharmacology. 22(4). 337–342. 62 indexed citations

10.

Widerl�v, E.. (1979). Dose-dependent pharmacokinetics of ?-methyl-p-tyrosine (?-MT) and comparison of catecholamine turnover rates after two doses of ?-MT. Journal of Neural Transmission. 44(3). 145–158. 35 indexed citations

11.

Widerl�v, E. & Tommy Lewander. (1978). The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 304(2). 125–134. 12 indexed citations

12.

Widerl�v, E. & Tommy Lewander. (1978). Tolerance to ?-methyl-p-tyrosine in rats: studies on the antagonism of amphetamine-induced motor activity and excitatory behaviour. Psychopharmacology. 60(1). 41–45. 4 indexed citations

13.

Widerl�v, E. & Tommy Lewander. (1978). Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after ?-methyl-p-tyrosine; time- and dose-response relationships. Naunyn-Schmiedeberg s Archives of Pharmacology. 304(2). 111–123. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact